Literature DB >> 17499686

Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia.

Mark I Neuman1, Meera Kelley, Marvin B Harper, Thomas M File, Carlos A Camargo.   

Abstract

We conducted a multicenter, retrospective cohort study of patients with Streptococcus pneumoniae bacteremia to determine factors associated with antibiotic resistance and mortality. Risk factors were identified using multivariate logistic regression. There were 1574 patients at 34 sites enrolled. Compared to isolates from patients not receiving an antibiotic before the index blood culture, patients receiving an antibiotic were less likely to harbor an antibiotic susceptible organism. Susceptibility to penicillin decreased from 78% (95% confidence interval [CI] 75-80) to 49% (95% CI 39-59); to cefotaxime/ceftriaxone, from 92% (95% CI 90-93) to 82% (95% CI 72-89); and to macrolide, from 84% (95% CI 82-87) to 55% (95% CI 41-68). Factors associated with macrolide non-susceptibility include: > 24 h of antibiotic therapy at time of the index culture (odds ratio [OR] 4.0), residing in southern U.S. (OR 1.7), and having an antibiotic allergy (OR 1.7). Harboring an antibiotic non-susceptible strain (OR 1.4) and male sex (OR 1.4) were associated with increased risk of mortality, whereas black race (OR 0.6) and evidence of focal infection (OR 0.6) were associated with decreased risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499686      PMCID: PMC2034392          DOI: 10.1016/j.jemermed.2006.08.014

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  26 in total

1.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

2.  Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.

Authors:  J D Heffelfinger; S F Dowell; J H Jorgensen; K P Klugman; L R Mabry; D M Musher; J F Plouffe; A Rakowsky; A Schuchat; C G Whitney
Journal:  Arch Intern Med       Date:  2000-05-22

3.  Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association.

Authors:  M S Niederman; J B Bass; G D Campbell; A M Fein; R F Grossman; L A Mandell; T J Marrie; G A Sarosi; A Torres; V L Yu
Journal:  Am Rev Respir Dis       Date:  1993-11

4.  Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.

Authors:  C Fogarty; R Goldschmidt; K Bush
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

5.  Reevaluation of outpatients with Streptococcus pneumoniae bacteremia.

Authors:  R Bachur; M B Harper
Journal:  Pediatrics       Date:  2000-03       Impact factor: 7.124

Review 6.  The growing threat of antibiotic-resistant Streptococcus pneumoniae.

Authors:  J R Lonks; A A Medeiros
Journal:  Med Clin North Am       Date:  1995-05       Impact factor: 5.456

7.  High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I.

Authors:  J R Lonks; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

8.  Antimicrobial resistance among isolates of respiratory tract infection pathogens from the southern United States: data from the PROTEKT US surveillance program 2000/2001.

Authors:  Ken Waites; Steve Brown
Journal:  South Med J       Date:  2003-10       Impact factor: 0.954

9.  Effect of antibiotic therapy on the outcome of outpatients with unsuspected bacteremia.

Authors:  M B Harper; R Bachur; G R Fleisher
Journal:  Pediatr Infect Dis J       Date:  1995-09       Impact factor: 2.129

10.  Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

Authors:  R Pallares; J Liñares; M Vadillo; C Cabellos; F Manresa; P F Viladrich; R Martin; F Gudiol
Journal:  N Engl J Med       Date:  1995-08-24       Impact factor: 91.245

View more
  9 in total

1.  Impact of penicillin nonsusceptibility on clinical outcomes of patients with nonmeningeal Streptococcus pneumoniae bacteremia in the era of the 2008 clinical and laboratory standards institute penicillin breakpoints.

Authors:  Seong-Ho Choi; Jin-Won Chung; Heungsup Sung; Mi-Na Kim; Sung-Han Kim; Sang-Oh Lee; Yang Soo Kim; Jun Hee Woo; Sang-Ho Choi
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

2.  Initial management of and outcome in patients with pneumococcal bacteremia: a retrospective study at a Swiss university hospital, 2003-2009.

Authors:  A-M Giner; S P Kuster; R Zbinden; C Ruef; B Ledergerber; R Weber
Journal:  Infection       Date:  2011-11-08       Impact factor: 3.553

Review 3.  Strategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of China.

Authors:  Vincent C C Cheng; Sally C Y Wong; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2015-02-11       Impact factor: 7.163

Review 4.  Pneumonia in the emergency department.

Authors:  Joseph F Plouffe; Daniel R Martin
Journal:  Emerg Med Clin North Am       Date:  2008-05       Impact factor: 2.264

Review 5.  Guidelines for the Evaluation and Treatment of Pneumonia.

Authors:  Samuel N Grief; Julie K Loza
Journal:  Prim Care       Date:  2018-09       Impact factor: 2.907

6.  Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis.

Authors:  Hao Chen; Hiromi Matsumoto; Nobuyuki Horita; Yu Hara; Nobuaki Kobayashi; Takeshi Kaneko
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

7.  Increase in pneumococcus macrolide resistance, United States.

Authors:  Stephen G Jenkins; David J Farrell
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

8.  Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia.

Authors:  Angel Vila-Corcoles; Ferran Bejarano-Romero; Elisabeth Salsench; Olga Ochoa-Gondar; Cinta de Diego; Frederic Gomez-Bertomeu; Xavier Raga-Luria; Xavier Cliville-Guasch; Victoria Arija
Journal:  BMC Infect Dis       Date:  2009-03-25       Impact factor: 3.090

9.  Bacteremic pneumococcal pneumonia: serotype distribution, antimicrobial susceptibility, severity scores, risk factors, and mortality in a single center in Chile.

Authors:  Alberto Fica; Nicolás Bunster; Felipe Aliaga; Felipe Olivares; Lorena Porte; Stephanie Braun; Jeannette Dabanch; Juan Carlos Hormázabal; Antonio Hernández; María Guacolda Benavides
Journal:  Braz J Infect Dis       Date:  2013-10-10       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.